Any entities that plan to invest or are already invested in digital health companies, entities that contract with them, or providers that offer in-house telehealth modalities must be aware of the significant regulatory oversight the industry faces. This article discusses the US Department of Health and Human Services Office of Inspector General's Special Fraud Alert published on July 20, 2022, which was the same day the US Department of Justice announced a massive fraud takedown, targeting telemedicine providers and physicians that netted criminal charges against 36 defendants in schemes that allegedly defrauded the government out of more than $1.2 billion.
Authors: Asher D. Funk, Jonathan M. Ishee, Erin S. Whaley, and Michael J. Paluzzi, Troutman Pepper Hamilton Sanders LLP
This article was originally published on the website of Troutman Pepper Hamilton Sanders LLP on July 25, 2022.